These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 28597399)
61. [Levosimendan. Clinical indications of a new vasoactive substance]. Braun JP; Döpfmer U; Kastrup M; Roots I; Borges A; Schneider M; Dohmen P; Kox W; Spies C Anaesthesist; 2004 Feb; 53(2):163-7. PubMed ID: 14991194 [TBL] [Abstract][Full Text] [Related]
62. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Landoni G; Mizzi A; Biondi-Zoccai G; Bignami E; Prati P; Ajello V; Marino G; Guarracino F; Zangrillo A Minerva Anestesiol; 2010 Apr; 76(4):276-86. PubMed ID: 20332741 [TBL] [Abstract][Full Text] [Related]
63. [LEVOSIMENDAN--THE FIRST 10 YEARS IN CLINICAL PRACTICE]. Rybka MM; Lobacheva GV Anesteziol Reanimatol; 2015; 60(5):80-4. PubMed ID: 26852586 [TBL] [Abstract][Full Text] [Related]
64. Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials. Silvetti S; Greco T; Di Prima AL; Mucchetti M; de Lurdes CM; Pasin L; Scandroglio M; Landoni G; Zangrillo A Clin Res Cardiol; 2014 Jul; 103(7):505-13. PubMed ID: 24368740 [TBL] [Abstract][Full Text] [Related]
65. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure. Lehtonen L Curr Heart Fail Rep; 2004 Sep; 1(3):136-44. PubMed ID: 16036037 [TBL] [Abstract][Full Text] [Related]
66. Levosimendan in cardiogenic shock: better than enoximone! Buerke M; Prondzinsky R Crit Care Med; 2008 Aug; 36(8):2450-1. PubMed ID: 18664796 [No Abstract] [Full Text] [Related]
67. Is there a place for levosimendan in the intensive care unit? Delaney A; Bradford C; McCaffrey J; Bagshaw SM; Lee R Crit Care Resusc; 2007 Sep; 9(3):290-2. PubMed ID: 17767458 [TBL] [Abstract][Full Text] [Related]
68. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144 [TBL] [Abstract][Full Text] [Related]
69. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis. Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934 [TBL] [Abstract][Full Text] [Related]
70. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics. García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404 [TBL] [Abstract][Full Text] [Related]
71. Levosimendan and pulmonary hypertension. Cavusoglu Y; Beyaztas A; Birdane A; Ata N J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805 [No Abstract] [Full Text] [Related]
72. Levosimendan: a retrospective single-center case series. Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721 [TBL] [Abstract][Full Text] [Related]
73. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study. Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637 [TBL] [Abstract][Full Text] [Related]
74. Repetitive infusion of levosimendan in patients with chronic heart failure: a meta-analysis. Yi GY; Li JX; Zhang J; Niu LL; Zhang CY Med Sci Monit; 2015 Mar; 21():895-901. PubMed ID: 25811545 [TBL] [Abstract][Full Text] [Related]
75. Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis. Lim JY; Deo SV; Rababa'h A; Altarabsheh SE; Cho YH; Hang D; McGraw M; Avery EG; Markowitz AH; Park SJ J Card Surg; 2015 Jul; 30(7):547-54. PubMed ID: 25989324 [TBL] [Abstract][Full Text] [Related]
76. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter? Yontar OC; Yilmaz MB; Yalta K; Tandoğan I Anadolu Kardiyol Derg; 2010 Aug; 10(4):310-6. PubMed ID: 20693125 [TBL] [Abstract][Full Text] [Related]
77. European experience on the practical use of levosimendan in patients with acute heart failure syndromes. Follath F; Franco F; Cardoso JS Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827 [TBL] [Abstract][Full Text] [Related]
78. Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model. du Toit E; Hofmann D; McCarthy J; Pineda C Heart; 2001 Jul; 86(1):81-7. PubMed ID: 11410569 [TBL] [Abstract][Full Text] [Related]
79. Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study. Kandasamy A; Simon HA; Murthy P; Annadurai M; Ali MM; Ramanathan G Ann Card Anaesth; 2017; 20(2):200-206. PubMed ID: 28393781 [TBL] [Abstract][Full Text] [Related]
80. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]